Skip to main content
Premium Trial:

Request an Annual Quote

Scott Binder, Yvonne Linney, Applied Biosystems


People in the News

Pathologist Scott Binder has joined CombiMatrix's wholly owned subsidiary, CombiMatrix Molecular Diagnostics, as a member of its scientific advisory board, Acacia Research said last week.

A professor of clinical pathology and dermatology, chief of dermatopathology, and director of pathology outreach services at the David Geffen School of Medicine at the University of California, Los Angeles, he is the founder and director of a dermatopathology fellowship training program in California.

Binder received his BA and MD from the University of Chicago Medical School, completed his residency at the Department of Pathology and Laboratory Medicine at UCLA, and was a fellow with the Scripps Clinic and Research Institute in La Jolla, Calif. He completed a preceptorship at New York University.

Yvonne Linney has left Caliper Life Sciences and is now head of molecular marketing for Bayer Diagnostics.

At Caliper, she was director of marketing. Before that, she held several directorial and managerial positions with Amersham Biosciences, now GE Healthcare.

New Product Watch

Applied Biosystems last week announced the availability of its TaqMan MicroRNA Reverse Transcription Kit. The company recommended the kit for use with its TaqMan MicroRNA Assays.

ABI said that components of this kit are used with the RT primer provided with the microRNA assay to convert miRNA to cDNA.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.